 | • レポートコード：MRC308GR09478 • 出版社/出版日：GlobalInfoResearch / 2023年8月 • レポート形態：英文、PDF、125ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
GlobalInfoResearchの最新の調査によると、世界の抗NeuN抗体の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界の抗NeuN抗体市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。
市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。
本レポートの主な目的は次のとおりです。
– 世界および主要国の市場機会の規模を決定するため
– 抗NeuN抗体の成長可能性を評価するため
– 各製品および最終用途市場の将来の成長を予測するため
– 市場に影響を与える競争要因を評価するため
抗NeuN抗体市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。
種類別セグメント
・モノクローナル、ポリクローナル
用途別セグメント
・免疫蛍光（IF）、免疫化学（IHC）、ウェスタンブロット（WB）、ELISA、その他
主要な市場プレーヤー
・GeneTex、Novus Biologicals、Bioss、United States Biological、Thermo Fisher Scientific、Biorbyt、Synaptic Systems GmbH、LifeSpan BioSciences、NSJ Bioreagents、EpiGentek、Cell Signaling Technology、G Biosciences、Abcam、HUABIO、Enzo Life Sciences、RayBiotech、Merck、Bio-Rad、RevMAb Biosciences、Miltenyi Biotec、Leading Biology
地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）
本調査レポートの内容は計15章あります。
・第1章では、抗NeuN抗体製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な抗NeuN抗体メーカーの企業概要、2019年～2022年までの抗NeuN抗体の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な抗NeuN抗体メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別抗NeuN抗体の販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までの抗NeuN抗体の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での抗NeuN抗体市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、および抗NeuN抗体の産業チェーンを掲載しています。
・第14、15章では、抗NeuN抗体の販売チャネル、販売業者、顧客、調査結果について説明します。
***** 目次(一部) *****
・市場概要
– 抗NeuN抗体の概要
– 種類別分析（2018年vs2022年vs2029年）：モノクローナル、ポリクローナル
– 用途別分析（2018年vs2022年vs2029年）：免疫蛍光（IF）、免疫化学（IHC）、ウェスタンブロット（WB）、ELISA、その他
– 世界の抗NeuN抗体市場規模・予測
– 世界の抗NeuN抗体生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– GeneTex、Novus Biologicals、Bioss、United States Biological、Thermo Fisher Scientific、Biorbyt、Synaptic Systems GmbH、LifeSpan BioSciences、NSJ Bioreagents、EpiGentek、Cell Signaling Technology、G Biosciences、Abcam、HUABIO、Enzo Life Sciences、RayBiotech、Merck、Bio-Rad、RevMAb Biosciences、Miltenyi Biotec、Leading Biology
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年：モノクローナル、ポリクローナル
・用途別分析2018年-2029年：免疫蛍光（IF）、免疫化学（IHC）、ウェスタンブロット（WB）、ELISA、その他
・抗NeuN抗体の北米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・抗NeuN抗体のヨーロッパ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・抗NeuN抗体のアジア市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・抗NeuN抗体の南米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・抗NeuN抗体の中東・アフリカ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
1 Market Overview
1.1 Product Overview and Scope of Anti-NeuN Antibody
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Anti-NeuN Antibody Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Monoclonal
1.3.3 Polyclonal
1.4 Market Analysis by Application
1.4.1 Overview: Global Anti-NeuN Antibody Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Immunofluorescence (IF)
1.4.3 Immunochemistry (IHC)
1.4.4 Western Blot (WB)
1.4.5 ELISA
1.4.6 Others
1.5 Global Anti-NeuN Antibody Market Size & Forecast
1.5.1 Global Anti-NeuN Antibody Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Anti-NeuN Antibody Sales Quantity (2018-2029)
1.5.3 Global Anti-NeuN Antibody Average Price (2018-2029)
2 Manufacturers Profiles
2.1 GeneTex
2.1.1 GeneTex Details
2.1.2 GeneTex Major Business
2.1.3 GeneTex Anti-NeuN Antibody Product and Services
2.1.4 GeneTex Anti-NeuN Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 GeneTex Recent Developments/Updates
2.2 Novus Biologicals
2.2.1 Novus Biologicals Details
2.2.2 Novus Biologicals Major Business
2.2.3 Novus Biologicals Anti-NeuN Antibody Product and Services
2.2.4 Novus Biologicals Anti-NeuN Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Novus Biologicals Recent Developments/Updates
2.3 Bioss
2.3.1 Bioss Details
2.3.2 Bioss Major Business
2.3.3 Bioss Anti-NeuN Antibody Product and Services
2.3.4 Bioss Anti-NeuN Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Bioss Recent Developments/Updates
2.4 United States Biological
2.4.1 United States Biological Details
2.4.2 United States Biological Major Business
2.4.3 United States Biological Anti-NeuN Antibody Product and Services
2.4.4 United States Biological Anti-NeuN Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 United States Biological Recent Developments/Updates
2.5 Thermo Fisher Scientific
2.5.1 Thermo Fisher Scientific Details
2.5.2 Thermo Fisher Scientific Major Business
2.5.3 Thermo Fisher Scientific Anti-NeuN Antibody Product and Services
2.5.4 Thermo Fisher Scientific Anti-NeuN Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Thermo Fisher Scientific Recent Developments/Updates
2.6 Biorbyt
2.6.1 Biorbyt Details
2.6.2 Biorbyt Major Business
2.6.3 Biorbyt Anti-NeuN Antibody Product and Services
2.6.4 Biorbyt Anti-NeuN Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Biorbyt Recent Developments/Updates
2.7 Synaptic Systems GmbH
2.7.1 Synaptic Systems GmbH Details
2.7.2 Synaptic Systems GmbH Major Business
2.7.3 Synaptic Systems GmbH Anti-NeuN Antibody Product and Services
2.7.4 Synaptic Systems GmbH Anti-NeuN Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Synaptic Systems GmbH Recent Developments/Updates
2.8 LifeSpan BioSciences
2.8.1 LifeSpan BioSciences Details
2.8.2 LifeSpan BioSciences Major Business
2.8.3 LifeSpan BioSciences Anti-NeuN Antibody Product and Services
2.8.4 LifeSpan BioSciences Anti-NeuN Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 LifeSpan BioSciences Recent Developments/Updates
2.9 NSJ Bioreagents
2.9.1 NSJ Bioreagents Details
2.9.2 NSJ Bioreagents Major Business
2.9.3 NSJ Bioreagents Anti-NeuN Antibody Product and Services
2.9.4 NSJ Bioreagents Anti-NeuN Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 NSJ Bioreagents Recent Developments/Updates
2.10 EpiGentek
2.10.1 EpiGentek Details
2.10.2 EpiGentek Major Business
2.10.3 EpiGentek Anti-NeuN Antibody Product and Services
2.10.4 EpiGentek Anti-NeuN Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 EpiGentek Recent Developments/Updates
2.11 Cell Signaling Technology
2.11.1 Cell Signaling Technology Details
2.11.2 Cell Signaling Technology Major Business
2.11.3 Cell Signaling Technology Anti-NeuN Antibody Product and Services
2.11.4 Cell Signaling Technology Anti-NeuN Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Cell Signaling Technology Recent Developments/Updates
2.12 G Biosciences
2.12.1 G Biosciences Details
2.12.2 G Biosciences Major Business
2.12.3 G Biosciences Anti-NeuN Antibody Product and Services
2.12.4 G Biosciences Anti-NeuN Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 G Biosciences Recent Developments/Updates
2.13 Abcam
2.13.1 Abcam Details
2.13.2 Abcam Major Business
2.13.3 Abcam Anti-NeuN Antibody Product and Services
2.13.4 Abcam Anti-NeuN Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Abcam Recent Developments/Updates
2.14 HUABIO
2.14.1 HUABIO Details
2.14.2 HUABIO Major Business
2.14.3 HUABIO Anti-NeuN Antibody Product and Services
2.14.4 HUABIO Anti-NeuN Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 HUABIO Recent Developments/Updates
2.15 Enzo Life Sciences
2.15.1 Enzo Life Sciences Details
2.15.2 Enzo Life Sciences Major Business
2.15.3 Enzo Life Sciences Anti-NeuN Antibody Product and Services
2.15.4 Enzo Life Sciences Anti-NeuN Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Enzo Life Sciences Recent Developments/Updates
2.16 RayBiotech
2.16.1 RayBiotech Details
2.16.2 RayBiotech Major Business
2.16.3 RayBiotech Anti-NeuN Antibody Product and Services
2.16.4 RayBiotech Anti-NeuN Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 RayBiotech Recent Developments/Updates
2.17 Merck
2.17.1 Merck Details
2.17.2 Merck Major Business
2.17.3 Merck Anti-NeuN Antibody Product and Services
2.17.4 Merck Anti-NeuN Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Merck Recent Developments/Updates
2.18 Bio-Rad
2.18.1 Bio-Rad Details
2.18.2 Bio-Rad Major Business
2.18.3 Bio-Rad Anti-NeuN Antibody Product and Services
2.18.4 Bio-Rad Anti-NeuN Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Bio-Rad Recent Developments/Updates
2.19 RevMAb Biosciences
2.19.1 RevMAb Biosciences Details
2.19.2 RevMAb Biosciences Major Business
2.19.3 RevMAb Biosciences Anti-NeuN Antibody Product and Services
2.19.4 RevMAb Biosciences Anti-NeuN Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 RevMAb Biosciences Recent Developments/Updates
2.20 Miltenyi Biotec
2.20.1 Miltenyi Biotec Details
2.20.2 Miltenyi Biotec Major Business
2.20.3 Miltenyi Biotec Anti-NeuN Antibody Product and Services
2.20.4 Miltenyi Biotec Anti-NeuN Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 Miltenyi Biotec Recent Developments/Updates
2.21 Leading Biology
2.21.1 Leading Biology Details
2.21.2 Leading Biology Major Business
2.21.3 Leading Biology Anti-NeuN Antibody Product and Services
2.21.4 Leading Biology Anti-NeuN Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.21.5 Leading Biology Recent Developments/Updates
3 Competitive Environment: Anti-NeuN Antibody by Manufacturer
3.1 Global Anti-NeuN Antibody Sales Quantity by Manufacturer (2018-2023)
3.2 Global Anti-NeuN Antibody Revenue by Manufacturer (2018-2023)
3.3 Global Anti-NeuN Antibody Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Anti-NeuN Antibody by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Anti-NeuN Antibody Manufacturer Market Share in 2022
3.4.2 Top 6 Anti-NeuN Antibody Manufacturer Market Share in 2022
3.5 Anti-NeuN Antibody Market: Overall Company Footprint Analysis
3.5.1 Anti-NeuN Antibody Market: Region Footprint
3.5.2 Anti-NeuN Antibody Market: Company Product Type Footprint
3.5.3 Anti-NeuN Antibody Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Anti-NeuN Antibody Market Size by Region
4.1.1 Global Anti-NeuN Antibody Sales Quantity by Region (2018-2029)
4.1.2 Global Anti-NeuN Antibody Consumption Value by Region (2018-2029)
4.1.3 Global Anti-NeuN Antibody Average Price by Region (2018-2029)
4.2 North America Anti-NeuN Antibody Consumption Value (2018-2029)
4.3 Europe Anti-NeuN Antibody Consumption Value (2018-2029)
4.4 Asia-Pacific Anti-NeuN Antibody Consumption Value (2018-2029)
4.5 South America Anti-NeuN Antibody Consumption Value (2018-2029)
4.6 Middle East and Africa Anti-NeuN Antibody Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Anti-NeuN Antibody Sales Quantity by Type (2018-2029)
5.2 Global Anti-NeuN Antibody Consumption Value by Type (2018-2029)
5.3 Global Anti-NeuN Antibody Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Anti-NeuN Antibody Sales Quantity by Application (2018-2029)
6.2 Global Anti-NeuN Antibody Consumption Value by Application (2018-2029)
6.3 Global Anti-NeuN Antibody Average Price by Application (2018-2029)
7 North America
7.1 North America Anti-NeuN Antibody Sales Quantity by Type (2018-2029)
7.2 North America Anti-NeuN Antibody Sales Quantity by Application (2018-2029)
7.3 North America Anti-NeuN Antibody Market Size by Country
7.3.1 North America Anti-NeuN Antibody Sales Quantity by Country (2018-2029)
7.3.2 North America Anti-NeuN Antibody Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Anti-NeuN Antibody Sales Quantity by Type (2018-2029)
8.2 Europe Anti-NeuN Antibody Sales Quantity by Application (2018-2029)
8.3 Europe Anti-NeuN Antibody Market Size by Country
8.3.1 Europe Anti-NeuN Antibody Sales Quantity by Country (2018-2029)
8.3.2 Europe Anti-NeuN Antibody Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Anti-NeuN Antibody Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Anti-NeuN Antibody Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Anti-NeuN Antibody Market Size by Region
9.3.1 Asia-Pacific Anti-NeuN Antibody Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Anti-NeuN Antibody Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Anti-NeuN Antibody Sales Quantity by Type (2018-2029)
10.2 South America Anti-NeuN Antibody Sales Quantity by Application (2018-2029)
10.3 South America Anti-NeuN Antibody Market Size by Country
10.3.1 South America Anti-NeuN Antibody Sales Quantity by Country (2018-2029)
10.3.2 South America Anti-NeuN Antibody Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Anti-NeuN Antibody Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Anti-NeuN Antibody Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Anti-NeuN Antibody Market Size by Country
11.3.1 Middle East & Africa Anti-NeuN Antibody Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Anti-NeuN Antibody Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Anti-NeuN Antibody Market Drivers
12.2 Anti-NeuN Antibody Market Restraints
12.3 Anti-NeuN Antibody Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Anti-NeuN Antibody and Key Manufacturers
13.2 Manufacturing Costs Percentage of Anti-NeuN Antibody
13.3 Anti-NeuN Antibody Production Process
13.4 Anti-NeuN Antibody Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Anti-NeuN Antibody Typical Distributors
14.3 Anti-NeuN Antibody Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table 1. Global Anti-NeuN Antibody Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Anti-NeuN Antibody Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. GeneTex Basic Information, Manufacturing Base and Competitors
Table 4. GeneTex Major Business
Table 5. GeneTex Anti-NeuN Antibody Product and Services
Table 6. GeneTex Anti-NeuN Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. GeneTex Recent Developments/Updates
Table 8. Novus Biologicals Basic Information, Manufacturing Base and Competitors
Table 9. Novus Biologicals Major Business
Table 10. Novus Biologicals Anti-NeuN Antibody Product and Services
Table 11. Novus Biologicals Anti-NeuN Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Novus Biologicals Recent Developments/Updates
Table 13. Bioss Basic Information, Manufacturing Base and Competitors
Table 14. Bioss Major Business
Table 15. Bioss Anti-NeuN Antibody Product and Services
Table 16. Bioss Anti-NeuN Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Bioss Recent Developments/Updates
Table 18. United States Biological Basic Information, Manufacturing Base and Competitors
Table 19. United States Biological Major Business
Table 20. United States Biological Anti-NeuN Antibody Product and Services
Table 21. United States Biological Anti-NeuN Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. United States Biological Recent Developments/Updates
Table 23. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 24. Thermo Fisher Scientific Major Business
Table 25. Thermo Fisher Scientific Anti-NeuN Antibody Product and Services
Table 26. Thermo Fisher Scientific Anti-NeuN Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Thermo Fisher Scientific Recent Developments/Updates
Table 28. Biorbyt Basic Information, Manufacturing Base and Competitors
Table 29. Biorbyt Major Business
Table 30. Biorbyt Anti-NeuN Antibody Product and Services
Table 31. Biorbyt Anti-NeuN Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Biorbyt Recent Developments/Updates
Table 33. Synaptic Systems GmbH Basic Information, Manufacturing Base and Competitors
Table 34. Synaptic Systems GmbH Major Business
Table 35. Synaptic Systems GmbH Anti-NeuN Antibody Product and Services
Table 36. Synaptic Systems GmbH Anti-NeuN Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Synaptic Systems GmbH Recent Developments/Updates
Table 38. LifeSpan BioSciences Basic Information, Manufacturing Base and Competitors
Table 39. LifeSpan BioSciences Major Business
Table 40. LifeSpan BioSciences Anti-NeuN Antibody Product and Services
Table 41. LifeSpan BioSciences Anti-NeuN Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. LifeSpan BioSciences Recent Developments/Updates
Table 43. NSJ Bioreagents Basic Information, Manufacturing Base and Competitors
Table 44. NSJ Bioreagents Major Business
Table 45. NSJ Bioreagents Anti-NeuN Antibody Product and Services
Table 46. NSJ Bioreagents Anti-NeuN Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. NSJ Bioreagents Recent Developments/Updates
Table 48. EpiGentek Basic Information, Manufacturing Base and Competitors
Table 49. EpiGentek Major Business
Table 50. EpiGentek Anti-NeuN Antibody Product and Services
Table 51. EpiGentek Anti-NeuN Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. EpiGentek Recent Developments/Updates
Table 53. Cell Signaling Technology Basic Information, Manufacturing Base and Competitors
Table 54. Cell Signaling Technology Major Business
Table 55. Cell Signaling Technology Anti-NeuN Antibody Product and Services
Table 56. Cell Signaling Technology Anti-NeuN Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Cell Signaling Technology Recent Developments/Updates
Table 58. G Biosciences Basic Information, Manufacturing Base and Competitors
Table 59. G Biosciences Major Business
Table 60. G Biosciences Anti-NeuN Antibody Product and Services
Table 61. G Biosciences Anti-NeuN Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. G Biosciences Recent Developments/Updates
Table 63. Abcam Basic Information, Manufacturing Base and Competitors
Table 64. Abcam Major Business
Table 65. Abcam Anti-NeuN Antibody Product and Services
Table 66. Abcam Anti-NeuN Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Abcam Recent Developments/Updates
Table 68. HUABIO Basic Information, Manufacturing Base and Competitors
Table 69. HUABIO Major Business
Table 70. HUABIO Anti-NeuN Antibody Product and Services
Table 71. HUABIO Anti-NeuN Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. HUABIO Recent Developments/Updates
Table 73. Enzo Life Sciences Basic Information, Manufacturing Base and Competitors
Table 74. Enzo Life Sciences Major Business
Table 75. Enzo Life Sciences Anti-NeuN Antibody Product and Services
Table 76. Enzo Life Sciences Anti-NeuN Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Enzo Life Sciences Recent Developments/Updates
Table 78. RayBiotech Basic Information, Manufacturing Base and Competitors
Table 79. RayBiotech Major Business
Table 80. RayBiotech Anti-NeuN Antibody Product and Services
Table 81. RayBiotech Anti-NeuN Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. RayBiotech Recent Developments/Updates
Table 83. Merck Basic Information, Manufacturing Base and Competitors
Table 84. Merck Major Business
Table 85. Merck Anti-NeuN Antibody Product and Services
Table 86. Merck Anti-NeuN Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 87. Merck Recent Developments/Updates
Table 88. Bio-Rad Basic Information, Manufacturing Base and Competitors
Table 89. Bio-Rad Major Business
Table 90. Bio-Rad Anti-NeuN Antibody Product and Services
Table 91. Bio-Rad Anti-NeuN Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 92. Bio-Rad Recent Developments/Updates
Table 93. RevMAb Biosciences Basic Information, Manufacturing Base and Competitors
Table 94. RevMAb Biosciences Major Business
Table 95. RevMAb Biosciences Anti-NeuN Antibody Product and Services
Table 96. RevMAb Biosciences Anti-NeuN Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 97. RevMAb Biosciences Recent Developments/Updates
Table 98. Miltenyi Biotec Basic Information, Manufacturing Base and Competitors
Table 99. Miltenyi Biotec Major Business
Table 100. Miltenyi Biotec Anti-NeuN Antibody Product and Services
Table 101. Miltenyi Biotec Anti-NeuN Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 102. Miltenyi Biotec Recent Developments/Updates
Table 103. Leading Biology Basic Information, Manufacturing Base and Competitors
Table 104. Leading Biology Major Business
Table 105. Leading Biology Anti-NeuN Antibody Product and Services
Table 106. Leading Biology Anti-NeuN Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Leading Biology Recent Developments/Updates
Table 108. Global Anti-NeuN Antibody Sales Quantity by Manufacturer (2018-2023) & (L)
Table 109. Global Anti-NeuN Antibody Revenue by Manufacturer (2018-2023) & (USD Million)
Table 110. Global Anti-NeuN Antibody Average Price by Manufacturer (2018-2023) & (US$/L)
Table 111. Market Position of Manufacturers in Anti-NeuN Antibody, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 112. Head Office and Anti-NeuN Antibody Production Site of Key Manufacturer
Table 113. Anti-NeuN Antibody Market: Company Product Type Footprint
Table 114. Anti-NeuN Antibody Market: Company Product Application Footprint
Table 115. Anti-NeuN Antibody New Market Entrants and Barriers to Market Entry
Table 116. Anti-NeuN Antibody Mergers, Acquisition, Agreements, and Collaborations
Table 117. Global Anti-NeuN Antibody Sales Quantity by Region (2018-2023) & (L)
Table 118. Global Anti-NeuN Antibody Sales Quantity by Region (2024-2029) & (L)
Table 119. Global Anti-NeuN Antibody Consumption Value by Region (2018-2023) & (USD Million)
Table 120. Global Anti-NeuN Antibody Consumption Value by Region (2024-2029) & (USD Million)
Table 121. Global Anti-NeuN Antibody Average Price by Region (2018-2023) & (US$/L)
Table 122. Global Anti-NeuN Antibody Average Price by Region (2024-2029) & (US$/L)
Table 123. Global Anti-NeuN Antibody Sales Quantity by Type (2018-2023) & (L)
Table 124. Global Anti-NeuN Antibody Sales Quantity by Type (2024-2029) & (L)
Table 125. Global Anti-NeuN Antibody Consumption Value by Type (2018-2023) & (USD Million)
Table 126. Global Anti-NeuN Antibody Consumption Value by Type (2024-2029) & (USD Million)
Table 127. Global Anti-NeuN Antibody Average Price by Type (2018-2023) & (US$/L)
Table 128. Global Anti-NeuN Antibody Average Price by Type (2024-2029) & (US$/L)
Table 129. Global Anti-NeuN Antibody Sales Quantity by Application (2018-2023) & (L)
Table 130. Global Anti-NeuN Antibody Sales Quantity by Application (2024-2029) & (L)
Table 131. Global Anti-NeuN Antibody Consumption Value by Application (2018-2023) & (USD Million)
Table 132. Global Anti-NeuN Antibody Consumption Value by Application (2024-2029) & (USD Million)
Table 133. Global Anti-NeuN Antibody Average Price by Application (2018-2023) & (US$/L)
Table 134. Global Anti-NeuN Antibody Average Price by Application (2024-2029) & (US$/L)
Table 135. North America Anti-NeuN Antibody Sales Quantity by Type (2018-2023) & (L)
Table 136. North America Anti-NeuN Antibody Sales Quantity by Type (2024-2029) & (L)
Table 137. North America Anti-NeuN Antibody Sales Quantity by Application (2018-2023) & (L)
Table 138. North America Anti-NeuN Antibody Sales Quantity by Application (2024-2029) & (L)
Table 139. North America Anti-NeuN Antibody Sales Quantity by Country (2018-2023) & (L)
Table 140. North America Anti-NeuN Antibody Sales Quantity by Country (2024-2029) & (L)
Table 141. North America Anti-NeuN Antibody Consumption Value by Country (2018-2023) & (USD Million)
Table 142. North America Anti-NeuN Antibody Consumption Value by Country (2024-2029) & (USD Million)
Table 143. Europe Anti-NeuN Antibody Sales Quantity by Type (2018-2023) & (L)
Table 144. Europe Anti-NeuN Antibody Sales Quantity by Type (2024-2029) & (L)
Table 145. Europe Anti-NeuN Antibody Sales Quantity by Application (2018-2023) & (L)
Table 146. Europe Anti-NeuN Antibody Sales Quantity by Application (2024-2029) & (L)
Table 147. Europe Anti-NeuN Antibody Sales Quantity by Country (2018-2023) & (L)
Table 148. Europe Anti-NeuN Antibody Sales Quantity by Country (2024-2029) & (L)
Table 149. Europe Anti-NeuN Antibody Consumption Value by Country (2018-2023) & (USD Million)
Table 150. Europe Anti-NeuN Antibody Consumption Value by Country (2024-2029) & (USD Million)
Table 151. Asia-Pacific Anti-NeuN Antibody Sales Quantity by Type (2018-2023) & (L)
Table 152. Asia-Pacific Anti-NeuN Antibody Sales Quantity by Type (2024-2029) & (L)
Table 153. Asia-Pacific Anti-NeuN Antibody Sales Quantity by Application (2018-2023) & (L)
Table 154. Asia-Pacific Anti-NeuN Antibody Sales Quantity by Application (2024-2029) & (L)
Table 155. Asia-Pacific Anti-NeuN Antibody Sales Quantity by Region (2018-2023) & (L)
Table 156. Asia-Pacific Anti-NeuN Antibody Sales Quantity by Region (2024-2029) & (L)
Table 157. Asia-Pacific Anti-NeuN Antibody Consumption Value by Region (2018-2023) & (USD Million)
Table 158. Asia-Pacific Anti-NeuN Antibody Consumption Value by Region (2024-2029) & (USD Million)
Table 159. South America Anti-NeuN Antibody Sales Quantity by Type (2018-2023) & (L)
Table 160. South America Anti-NeuN Antibody Sales Quantity by Type (2024-2029) & (L)
Table 161. South America Anti-NeuN Antibody Sales Quantity by Application (2018-2023) & (L)
Table 162. South America Anti-NeuN Antibody Sales Quantity by Application (2024-2029) & (L)
Table 163. South America Anti-NeuN Antibody Sales Quantity by Country (2018-2023) & (L)
Table 164. South America Anti-NeuN Antibody Sales Quantity by Country (2024-2029) & (L)
Table 165. South America Anti-NeuN Antibody Consumption Value by Country (2018-2023) & (USD Million)
Table 166. South America Anti-NeuN Antibody Consumption Value by Country (2024-2029) & (USD Million)
Table 167. Middle East & Africa Anti-NeuN Antibody Sales Quantity by Type (2018-2023) & (L)
Table 168. Middle East & Africa Anti-NeuN Antibody Sales Quantity by Type (2024-2029) & (L)
Table 169. Middle East & Africa Anti-NeuN Antibody Sales Quantity by Application (2018-2023) & (L)
Table 170. Middle East & Africa Anti-NeuN Antibody Sales Quantity by Application (2024-2029) & (L)
Table 171. Middle East & Africa Anti-NeuN Antibody Sales Quantity by Region (2018-2023) & (L)
Table 172. Middle East & Africa Anti-NeuN Antibody Sales Quantity by Region (2024-2029) & (L)
Table 173. Middle East & Africa Anti-NeuN Antibody Consumption Value by Region (2018-2023) & (USD Million)
Table 174. Middle East & Africa Anti-NeuN Antibody Consumption Value by Region (2024-2029) & (USD Million)
Table 175. Anti-NeuN Antibody Raw Material
Table 176. Key Manufacturers of Anti-NeuN Antibody Raw Materials
Table 177. Anti-NeuN Antibody Typical Distributors
Table 178. Anti-NeuN Antibody Typical Customers
List of Figures
Figure 1. Anti-NeuN Antibody Picture
Figure 2. Global Anti-NeuN Antibody Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Anti-NeuN Antibody Consumption Value Market Share by Type in 2022
Figure 4. Monoclonal Examples
Figure 5. Polyclonal Examples
Figure 6. Global Anti-NeuN Antibody Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Anti-NeuN Antibody Consumption Value Market Share by Application in 2022
Figure 8. Immunofluorescence (IF) Examples
Figure 9. Immunochemistry (IHC) Examples
Figure 10. Western Blot (WB) Examples
Figure 11. ELISA Examples
Figure 12. Others Examples
Figure 13. Global Anti-NeuN Antibody Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Anti-NeuN Antibody Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Anti-NeuN Antibody Sales Quantity (2018-2029) & (L)
Figure 16. Global Anti-NeuN Antibody Average Price (2018-2029) & (US$/L)
Figure 17. Global Anti-NeuN Antibody Sales Quantity Market Share by Manufacturer in 2022
Figure 18. Global Anti-NeuN Antibody Consumption Value Market Share by Manufacturer in 2022
Figure 19. Producer Shipments of Anti-NeuN Antibody by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 20. Top 3 Anti-NeuN Antibody Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Top 6 Anti-NeuN Antibody Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Global Anti-NeuN Antibody Sales Quantity Market Share by Region (2018-2029)
Figure 23. Global Anti-NeuN Antibody Consumption Value Market Share by Region (2018-2029)
Figure 24. North America Anti-NeuN Antibody Consumption Value (2018-2029) & (USD Million)
Figure 25. Europe Anti-NeuN Antibody Consumption Value (2018-2029) & (USD Million)
Figure 26. Asia-Pacific Anti-NeuN Antibody Consumption Value (2018-2029) & (USD Million)
Figure 27. South America Anti-NeuN Antibody Consumption Value (2018-2029) & (USD Million)
Figure 28. Middle East & Africa Anti-NeuN Antibody Consumption Value (2018-2029) & (USD Million)
Figure 29. Global Anti-NeuN Antibody Sales Quantity Market Share by Type (2018-2029)
Figure 30. Global Anti-NeuN Antibody Consumption Value Market Share by Type (2018-2029)
Figure 31. Global Anti-NeuN Antibody Average Price by Type (2018-2029) & (US$/L)
Figure 32. Global Anti-NeuN Antibody Sales Quantity Market Share by Application (2018-2029)
Figure 33. Global Anti-NeuN Antibody Consumption Value Market Share by Application (2018-2029)
Figure 34. Global Anti-NeuN Antibody Average Price by Application (2018-2029) & (US$/L)
Figure 35. North America Anti-NeuN Antibody Sales Quantity Market Share by Type (2018-2029)
Figure 36. North America Anti-NeuN Antibody Sales Quantity Market Share by Application (2018-2029)
Figure 37. North America Anti-NeuN Antibody Sales Quantity Market Share by Country (2018-2029)
Figure 38. North America Anti-NeuN Antibody Consumption Value Market Share by Country (2018-2029)
Figure 39. United States Anti-NeuN Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Canada Anti-NeuN Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Mexico Anti-NeuN Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Europe Anti-NeuN Antibody Sales Quantity Market Share by Type (2018-2029)
Figure 43. Europe Anti-NeuN Antibody Sales Quantity Market Share by Application (2018-2029)
Figure 44. Europe Anti-NeuN Antibody Sales Quantity Market Share by Country (2018-2029)
Figure 45. Europe Anti-NeuN Antibody Consumption Value Market Share by Country (2018-2029)
Figure 46. Germany Anti-NeuN Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. France Anti-NeuN Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. United Kingdom Anti-NeuN Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Russia Anti-NeuN Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Italy Anti-NeuN Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Asia-Pacific Anti-NeuN Antibody Sales Quantity Market Share by Type (2018-2029)
Figure 52. Asia-Pacific Anti-NeuN Antibody Sales Quantity Market Share by Application (2018-2029)
Figure 53. Asia-Pacific Anti-NeuN Antibody Sales Quantity Market Share by Region (2018-2029)
Figure 54. Asia-Pacific Anti-NeuN Antibody Consumption Value Market Share by Region (2018-2029)
Figure 55. China Anti-NeuN Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Japan Anti-NeuN Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Korea Anti-NeuN Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. India Anti-NeuN Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Southeast Asia Anti-NeuN Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Australia Anti-NeuN Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. South America Anti-NeuN Antibody Sales Quantity Market Share by Type (2018-2029)
Figure 62. South America Anti-NeuN Antibody Sales Quantity Market Share by Application (2018-2029)
Figure 63. South America Anti-NeuN Antibody Sales Quantity Market Share by Country (2018-2029)
Figure 64. South America Anti-NeuN Antibody Consumption Value Market Share by Country (2018-2029)
Figure 65. Brazil Anti-NeuN Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Argentina Anti-NeuN Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Middle East & Africa Anti-NeuN Antibody Sales Quantity Market Share by Type (2018-2029)
Figure 68. Middle East & Africa Anti-NeuN Antibody Sales Quantity Market Share by Application (2018-2029)
Figure 69. Middle East & Africa Anti-NeuN Antibody Sales Quantity Market Share by Region (2018-2029)
Figure 70. Middle East & Africa Anti-NeuN Antibody Consumption Value Market Share by Region (2018-2029)
Figure 71. Turkey Anti-NeuN Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Egypt Anti-NeuN Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Saudi Arabia Anti-NeuN Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. South Africa Anti-NeuN Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Anti-NeuN Antibody Market Drivers
Figure 76. Anti-NeuN Antibody Market Restraints
Figure 77. Anti-NeuN Antibody Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Anti-NeuN Antibody in 2022
Figure 80. Manufacturing Process Analysis of Anti-NeuN Antibody
Figure 81. Anti-NeuN Antibody Industrial Chain
Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source